![]() |
市場調查報告書
商品編碼
2102733
獸醫眼科市場:全球市場預測,2026-2032年Veterinary Eye Care Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,獸醫眼科市場將成長至 83.4 億美元,複合年成長率為 7.53%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 50.1億美元 |
| 預計年份:2026年 | 53.7億美元 |
| 預測年份 2032 | 83.4億美元 |
| 複合年成長率 (%) | 7.53% |
隨著寵物數量的增加、動物壽命的延長以及越來越多的飼主尋求針對威脅視力疾病的專科治療,獸醫眼科學正成為伴侶動物、馬匹和生產動物健康管理的重要組成部分。獸醫眼科學的關鍵領域包括白內障、青光眼、角膜潰瘍、角膜乾燥症角結膜炎、葡萄膜炎、視網膜疾病、眼外傷、先天性眼科疾病以及感染性或免疫介導性眼科疾病的診斷和治療。推動這一需求成長的因素包括:動物福利意識的提高、專科轉診網路的改善、眼壓測量、裂隙燈顯微鏡檢查、超音波超音波檢查、視網膜電圖檢查、眼底成像和光學同調斷層掃描(OCT)等先進診斷技術的廣泛應用,以及包括超音波超音波乳化術和角膜修復術在內的手術選擇的擴展。
目前,獸醫眼科學的發展得益於專業獸醫眼科學會制定的臨床指南、全科獸醫繼續教育的加強以及眼科篩檢在預防醫學中日益普及。伴侶動物仍然是臨床關注的重點,因為犬貓經常出現與遺傳、老齡化、發炎、外傷和全身性疾病相關的眼睛問題。同時,家畜和馬的眼科學在生產力、福利、生物安全和生產性能方面也發揮著至關重要的作用。該領域正從被動治療發展到早期診斷、多方面疾病管理、數位化影像、遠距醫療支援和個人化治療方案。
隨著臨床實踐從基礎檢查和臨時治療轉向綜合眼科診療路徑,獸醫眼科正在經歷結構性變革。綜合動物醫院擴大採用諸如反彈眼壓測量、螢光素染色、淚液分泌試驗、間接眼底鏡檢查和數位眼底鏡成像等篩檢工具,從而能夠儘早將疑難病例轉診給專科醫生。這種轉變對於青光眼、角膜潰瘍、白內障和視網膜疾病尤其重要,因為延誤治療可能導致不可逆的視力喪失或眼球摘除。
人工智慧(AI)正透過影像分析、工作流程自動化、診斷支援和臨床決策支援等方式,開始對獸醫眼科產生影響。利用人工智慧分析眼部照片、眼底影像和其他診斷結果,有助於識別角膜混濁、水晶體變化、視網膜病變、視神經變化以及與發炎或退化性疾病相符的徵兆等異常情況。雖然專門用於獸醫學的人工智慧工具仍不如其在人類眼科領域的應用成熟,但電腦視覺、模式識別和自動影像分割方面的基礎性進展在獸醫臨床實踐中正變得日益重要。
在亞太地區,隨著都市區寵物飼養、小型動物診所和專科轉診服務在主要經濟體的擴展,獸醫眼科學日益受到關注。在日本、澳洲、韓國、中國和印度等大都會圈基礎設施完善的國家,眼科診斷、白內障評估、青光眼監測和角膜疾病管理正變得越來越普及。然而,區域差異仍然顯著。雖然先進的都市區診所擴大提供專科轉診和手術服務,但農村地區通常依賴全科醫生、大學獸醫醫院和公共動物保健服務來獲得複雜的眼科護理。
東協市場的特點是快速的都市化、伴侶動物數量的成長以及對小型動物獸醫服務需求的增加。隨著診所採用基礎眼科診斷技術以及主要城市建立轉診網路,獸醫眼科在該地區的重要性日益凸顯。鑑於該地區獸醫基礎設施的多樣性,培訓、價格合理的診斷工具和遠距醫療可以在改善眼科醫療服務的可近性方面發揮關鍵作用。
美國擁有世界上最先進的獸醫眼科醫療體系之一,其專科轉診網路、獸醫教學醫院、繼續教育計畫以及先進的診斷技術和眼科手術資源都非常豐富。加拿大同樣重視伴侶動物健康和專科轉診服務,建立了高標準的臨床規範,並且越來越關注老年寵物的慢性眼科疾病。在墨西哥,伴侶動物醫療的普及正在提升都市區的獸醫眼科診療能力,私人診所也正在增加對診斷設備的投入。
業界領導者應優先考慮早期發現,為基層醫療診所配備實用的眼科工具和標準化診療流程,以應對紅眼、角膜潰瘍、疑似青光眼、白內障評估、眼外傷和突發性視力喪失等情況。培訓全科醫生識別緊急眼科疾病可以減少可預防的失明,並提高轉診品質。
本執行摘要採用系統化的二手研究途徑編寫,重點關注檢驗的獸醫、臨床、監管和專業資訊來源。該調查方法強調同行評審的獸醫眼科學文獻、臨床指南、獸醫協會資源、大學動物醫院出版刊物、動物福利框架、監管材料以及公開的診斷和治療標準資訊。
獸醫眼科學正朝著更專業、技術驅動且以動物福利為中心的領域發展。隨著人們對伴侶動物、馬匹和牲畜眼科疾病的認知不斷提高,早期診斷、高品質的轉診系統、先進的影像技術、有效的藥物治療和熟練的外科手術干預的重要性日益凸顯。白內障、青光眼、角膜潰瘍、乾眼症、視網膜疾病、葡萄膜炎和眼外傷等疾病需要及時的臨床干預,眼科專業能力已成為現代獸醫學中至關重要的區分因素。
The Veterinary Eye Care Market is projected to grow by USD 8.34 billion at a CAGR of 7.53% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 5.01 billion |
| Estimated Year [2026] | USD 5.37 billion |
| Forecast Year [2032] | USD 8.34 billion |
| CAGR (%) | 7.53% |
Veterinary eye care is becoming an essential component of companion animal, equine, and production animal health as pet ownership rises, animals live longer, and owners increasingly seek specialized treatment for vision-threatening conditions. Core areas of veterinary ophthalmology include diagnosis and management of cataracts, glaucoma, corneal ulcers, keratoconjunctivitis sicca, uveitis, retinal disease, trauma, congenital eye disorders, and infectious or immune-mediated ocular conditions. Demand is being shaped by greater awareness of animal welfare, improved access to specialty referral networks, expanding use of advanced diagnostics such as tonometry, slit-lamp biomicroscopy, ocular ultrasound, electroretinography, fundus imaging, optical coherence tomography, and wider availability of surgical procedures including phacoemulsification and corneal repair.
The veterinary eye care landscape is supported by established clinical guidance from professional veterinary ophthalmology associations, increasing continuing education for general practitioners, and growing integration of ophthalmic screening into preventive care. Companion animals remain a major clinical focus because dogs and cats frequently present with inherited, age-related, inflammatory, traumatic, and systemic disease-related ocular problems. At the same time, livestock and equine eye care remains important for productivity, welfare, biosecurity, and performance outcomes. The sector is advancing from reactive treatment toward earlier diagnosis, multimodal disease management, digital imaging, teleconsultation support, and personalized therapeutic planning.
Veterinary eye care is undergoing structural change as clinical practice shifts from basic examination and episodic treatment toward integrated ophthalmic care pathways. General veterinary clinics are increasingly adopting screening tools such as rebound tonometry, fluorescein staining, Schirmer tear testing, indirect ophthalmoscopy, and digital ocular imaging, enabling earlier referral for complex cases. This transition is especially important for glaucoma, corneal ulcers, cataracts, and retinal disease, where delayed intervention can result in irreversible vision loss or eye removal.
Another transformative shift is the rise of specialty and referral-based care. Board-certified veterinary ophthalmologists and advanced clinical teams are managing more complex surgical and medical cases, while primary veterinarians remain central to detection, triage, long-term monitoring, and owner education. The increasing use of minimally invasive cataract surgery, improved intraocular lenses, advanced corneal grafting techniques, cryotherapy, laser procedures, and refined postoperative protocols is improving clinical options for animals with vision impairment.
Digital transformation is also changing the veterinary ophthalmology workflow. High-resolution anterior and posterior segment imaging, cloud-based case sharing, teleophthalmology support, electronic medical records, and remote expert review are improving documentation and continuity of care. In parallel, pharmaceutical innovation in anti-infective, anti-inflammatory, immunomodulatory, tear-support, and intraocular pressure-lowering therapies is supporting more targeted long-term disease management. These shifts are reinforcing veterinary eye care as a specialized, technology-enabled, and welfare-driven field.
Artificial intelligence is beginning to influence veterinary eye care through image interpretation, workflow automation, diagnostic support, and clinical decision assistance. AI-enabled analysis of ocular photographs, fundus images, and other diagnostic outputs can help flag abnormalities such as corneal opacity, lens changes, retinal lesions, optic nerve alterations, and signs consistent with inflammatory or degenerative disease. While veterinary-specific AI tools remain less mature than human ophthalmology applications, the same underlying advances in computer vision, pattern recognition, and automated image segmentation are increasingly relevant to veterinary clinical use.
The cumulative impact of AI is expected to be most visible in screening and triage rather than autonomous diagnosis. In busy primary care environments, AI-supported tools can help standardize image capture, prioritize urgent cases, reduce missed abnormalities, and guide referral decisions. For specialty practices, AI can support longitudinal monitoring by comparing serial images, improving measurement consistency, and helping clinicians evaluate disease progression or treatment response. AI also has potential in education, where annotated image libraries and decision-support systems can help general veterinarians recognize common ocular emergencies.
However, responsible deployment requires validated datasets across species, breeds, ages, coat pigmentation, ocular anatomy, and disease presentations. Bias, image quality variation, limited labeled veterinary datasets, and regulatory uncertainty remain important constraints. AI should therefore be positioned as an augmentative clinical tool that supports veterinary ophthalmologists and primary care teams, not as a replacement for professional examination, diagnostic testing, clinical reasoning, or owner-informed treatment planning.
Asia-Pacific is experiencing rising attention to veterinary eye care as urban pet ownership, small animal clinics, and specialty referral services expand across major economies. Countries with mature veterinary infrastructure, including Japan, Australia, South Korea, China, and India's metropolitan centers, are seeing greater use of ophthalmic diagnostics, cataract evaluation, glaucoma monitoring, and corneal disease management. Regional diversity remains significant: advanced urban clinics increasingly offer specialist referral and surgical services, while rural areas often depend on general practitioners, academic veterinary hospitals, and public animal health services for complex ophthalmic care.
North America represents one of the most developed environments for veterinary ophthalmology, supported by high companion animal healthcare spending, dense referral networks, veterinary teaching hospitals, specialty certification pathways, and widespread access to advanced diagnostics and surgery. The United States and Canada benefit from established continuing education systems and strong owner awareness of chronic conditions such as dry eye, cataracts, glaucoma, ocular trauma, and age-related retinal disease.
Latin America is advancing through expanding companion animal care, growing veterinary education, and rising demand for specialty services in urban centers. Brazil and Mexico are particularly important for regional clinical activity, with increased adoption of diagnostic equipment and referral pathways in larger cities. Access disparities remain between urban and rural settings, making clinician training, affordable diagnostics, and scalable screening tools important for broader veterinary eye care delivery.
Europe benefits from strong animal welfare standards, specialist training structures, and well-developed small animal veterinary services. Countries such as the United Kingdom, Germany, France, Italy, and Spain show established demand for advanced ophthalmic diagnostics and surgery, while broader European welfare expectations support high standards in companion animal, equine, and livestock eye care.
The Middle East is seeing growth in premium companion animal services and equine ophthalmology, particularly in countries with strong veterinary investment and high-value equestrian sectors. Referral care, advanced imaging, and surgical capability are becoming more prominent in major urban centers. Africa presents a mixed landscape, with veterinary eye care shaped by companion animal growth in urban markets, livestock health priorities, equine needs, and the role of universities, welfare organizations, and mobile veterinary services in expanding access to diagnosis and treatment.
ASEAN markets are characterized by rapid urbanization, growing companion animal ownership, and increasing demand for small animal veterinary services. Veterinary eye care in this group is gaining relevance as clinics adopt basic ophthalmic diagnostics and referral networks improve in major cities. The region's varied veterinary infrastructure means that training, affordable diagnostic tools, and teleconsultation can play a significant role in improving access to ocular care.
The GCC is distinguished by strong demand for premium veterinary services, companion animal care, falconry medicine, and equine medicine. Veterinary ophthalmology is supported by investment in modern clinics, advanced diagnostic equipment, and specialist referral capability in leading urban centers. Equine eye care is particularly relevant due to the region's established racing, breeding, endurance, and performance horse sectors.
The European Union provides a structured environment for veterinary eye care through animal welfare policy, veterinary education, cross-border professional collaboration, pharmacovigilance systems, and high expectations for clinical standards. EU countries also benefit from widespread adoption of companion animal preventive care and a strong base of specialty referral practices.
BRICS countries represent diverse but influential veterinary healthcare environments. Brazil, Russia, India, China, and South Africa combine large animal populations, expanding urban pet care, and growing veterinary education ecosystems. Veterinary eye care development in BRICS economies is closely linked to rising middle-class pet ownership, expansion of private clinics, academic veterinary capacity, and increasing availability of advanced diagnostics in metropolitan areas.
G7 countries generally demonstrate mature veterinary healthcare systems, strong purchasing power for companion animal care, and greater access to specialist-led ophthalmology services. These countries tend to lead in advanced surgical adoption, clinical training, imaging technologies, antimicrobial stewardship, and long-term management of chronic ocular disease.
NATO countries span North America and Europe and include many advanced veterinary systems where military working dogs, service animals, equine units, and companion animals contribute to demand for high-quality ocular care. Across these countries, veterinary eye care is supported by professional training, referral medicine, emergency care capacity, and growing recognition of ocular health as part of animal welfare and operational readiness for working animals.
The United States has one of the most advanced veterinary eye care ecosystems, with extensive specialty referral networks, veterinary teaching hospitals, continuing education programs, and broad access to advanced diagnostics and ophthalmic surgery. Canada shows similar emphasis on companion animal wellness and specialty referral care, with strong clinical standards and increasing attention to chronic ocular disease in aging pets. Mexico is expanding veterinary ophthalmology capability in urban centers as companion animal care grows and private clinics invest in diagnostic equipment.
Brazil is a leading Latin American market for veterinary services, supported by a large companion animal population, active veterinary education, and rising demand for specialized procedures. The United Kingdom maintains strong standards in small animal and equine ophthalmology, supported by referral practices, professional accreditation, and owner awareness. Germany, France, Italy, and Spain benefit from mature veterinary infrastructure, established companion animal care, and demand for cataract surgery, glaucoma management, corneal procedures, and diagnostic imaging. Russia has a sizable pet population and a developing specialty care landscape, with advanced services concentrated in major cities.
China is experiencing rapid growth in companion animal healthcare in metropolitan areas, driving demand for modern diagnostics, specialty referrals, and owner education around eye diseases. India's veterinary eye care development is supported by a large animal population, expanding pet care sector, veterinary colleges, and strong need for scalable services across both companion animal and livestock contexts. Japan has sophisticated veterinary services, high standards for small animal medicine, and strong demand for care related to aging pets. Australia combines advanced companion animal care, equine medicine, livestock health expertise, and academic veterinary capability, while South Korea's urban pet care culture is supporting adoption of advanced diagnostics, specialty services, and preventive ophthalmic evaluation.
Industry leaders should prioritize early-detection pathways by equipping primary care clinics with practical ophthalmic tools and standardized protocols for red eye, corneal ulcer, glaucoma suspicion, cataract assessment, ocular trauma, and sudden vision loss. Training general practitioners to recognize urgent ocular conditions can reduce preventable blindness and improve referral quality.
Investment in specialist collaboration is essential. Clinics, hospitals, and distributors should strengthen referral networks, teleophthalmology partnerships, and shared imaging workflows to improve access where veterinary ophthalmology specialists are limited. Educational programs for pet owners should emphasize warning signs such as squinting, ocular discharge, cloudiness, eye rubbing, redness, light sensitivity, and behavioral signs of vision loss.
Leaders should also support evidence-based technology adoption. Advanced imaging, tonometry, ocular ultrasound, electroretinography, and surgical systems should be paired with training, maintenance, and clinical governance. AI-enabled tools should be implemented only when supported by validation, transparent performance metrics, clinician oversight, and data privacy safeguards.
Pharmaceutical and device stakeholders can improve outcomes by focusing on species-appropriate formulations, adherence-friendly dosing, pain control, antimicrobial stewardship, and therapies for chronic diseases such as dry eye, uveitis, and glaucoma. Across all segments, success depends on integrating animal welfare, clinical quality, affordability, and accessible owner communication into the veterinary eye care model.
This executive summary is developed through a structured secondary research approach focused on verified veterinary, clinical, regulatory, and professional sources. The methodology emphasizes peer-reviewed veterinary ophthalmology literature, clinical guidelines, veterinary association resources, academic veterinary hospital publications, animal welfare frameworks, regulatory references, and publicly available information on diagnostic and therapeutic standards.
The research process examines disease burden by condition type, species-specific clinical needs, diagnostic and surgical technology adoption, specialist referral structures, regional veterinary infrastructure, companion animal ownership trends, livestock and equine health priorities, and digital health developments. Regional, group, and country insights are interpreted using observable healthcare system maturity, veterinary education capacity, urban clinic development, welfare standards, and access to advanced ophthalmic services.
To maintain reliability, the analysis avoids unverified claims, speculative projections, market sizing, market estimation, market share statements, and unsupported forecasts. Insights are synthesized qualitatively to support strategic decision-making for veterinary service providers, device and pharmaceutical stakeholders, distributors, policymakers, academic institutions, and animal health organizations.
Veterinary eye care is evolving into a more specialized, technology-enabled, and welfare-centered field. The growing recognition of ocular disease in companion animals, equine patients, and livestock is increasing the importance of early diagnosis, high-quality referral pathways, advanced imaging, effective pharmaceuticals, and skilled surgical intervention. Conditions such as cataracts, glaucoma, corneal ulcers, dry eye, retinal disease, uveitis, and ocular trauma require timely clinical attention, making ophthalmic capability a key differentiator in modern veterinary practice.
Regional development is uneven but steadily advancing, with mature systems in North America, Europe, Japan, Australia, and South Korea, rapid urban growth in Asia-Pacific and Latin America, premium service expansion in the Middle East, and access-focused opportunities across Africa. AI, teleophthalmology, and digital imaging can improve screening and continuity of care when used responsibly alongside professional veterinary judgment.
Industry leaders that invest in training, validated technology, specialist collaboration, owner education, and accessible care models will be best positioned to improve animal vision outcomes and strengthen the role of veterinary ophthalmology within comprehensive animal health.